ASCO 2019 Use of broader criteria for clinical trial enrolment would double number of eligible patients With lung cancer

ASCO 2019: Use of broader criteria for clinical trial enrolment would double number of eligible patients With lung cancer

A study looking at 10,500 health records of advanced non-small cell lung cancer (aNSCLC) patients from ASCO’s CancerLinQ database found that the use of expanded clinical trial inclusion criteria, as proposed by ASCO and Friends of Cancer Research in...

More From BioPortfolio on "ASCO 2019: Use of broader criteria for clinical trial enrolment would double number of eligible patients With lung cancer"